As news continues to spread about an outbreak of a rare form of meningitis, it’s important to note — Oklahoma has not seen any cases nor is the state Health Department investigating any cases of fungal meningitis associated with the outbreak.
The Centers for Disease Control and Prevention has confirmed 35 cases of the rare form of meningitis in six states, and at least five deaths, all associated with the outbreak.
A Massachusetts compounding pharmacy, the New England Compounding Center, is under federal investigation after three lots of a steroid used to treat back pain that the center shipped to 23 states were thought to be the cause of the outbreak.
States where the lots were shipped include: California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana , Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas and West Virginia.
The New England Compounding Center does have a license from the Oklahoma State Board of Pharmacy. This means there could be products from the compounding center in Oklahoma. It’s not known whether products outside of the contaminated lot are also contaminated, for the federal investigation is ongoing.